Study of Safety and Efficacy of MGCND00EP1 as an Add on Treatment in Children and Adolescents With Resistant Epilepsies

NCT04406948 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Failure to overcome bureaucratic obstacles within timeframe.

Conditions

Resistant Epilepsy, Drug
Adolescent Epilepsy
Children Epilepsy
Children and Adolescents With Resistant Epilepsies

Interventions

DRUG: MGCND00EP1
DRUG: Placebo
DIAGNOSTIC_TEST: ECG
DIAGNOSTIC_TEST: EEG
DIAGNOSTIC_TEST: Blood and urine collection

Sponsor

MGC Pharmaceuticals d.o.o